Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-135-5 | CAS number: 7440-25-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2022-03-11 to 2022-10-03
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Version / remarks:
- Adopted: 25 June 2018
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Ditantalum pentaoxide
- EC Number:
- 215-238-2
- EC Name:
- Ditantalum pentaoxide
- Cas Number:
- 1314-61-0
- Molecular formula:
- O5Ta2
- IUPAC Name:
- ditantalum pentaoxide
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source :Sponsor
- Batch: 210515
- Purity: 99.9%
- Expiry Date:12 November 2026 (shelf life)
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Crl: WI(Han).
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany or Charles River Laboratories France, L'Arbresle Cedex, France.
- Age at study initiation: 10-14 weeks
- Weight at study initiation: 180-230 g
- Fasting period before study: not stated
- Housing: Polycarbonate cages (Makrolon type MIII, height 18 cm) containing sterilized wooden fibers as bedding item (Lignocel S 8-15, JRS-J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) equipped with water bottles.
Animals will be individually housed.
- Diet: SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany, ad libitum
- Water: tap water ad libitum
- Acclimatisation period: At least 5 days prior to dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-24
- Humidity (%): 40-70
- Air changes (per hr): At least 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: To:
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
During the current study, the test item dosing formulations were prepared with corn oil. As
the substance is a metal compound and did not dissolve in concentrated nitric acid, nitric
acid/hydrogen peroxide or concentrated hydrochloric acid, the substance was also not
expected to react with any oil-like substance like corn oil and thus was expected to be stable
in corn oil for the period from formulation until administration.
In addition, to limit the impact, the test item preparation were performed with approved
procedures and documented in detail. Formulations were visually inspected for homogeneity
prior to use and all formulations were used within 2 hours after adding vehicle to the test
item. Additionally, test item formulations were prepared protected from light.
VEHICLE
- Justification for use and choice of vehicle (if other than water): ditantalum pentaoxide did not dissolve in aqueous solutions
- Amount of vehicle (if gavage): 4 mL/kg - Analytical verification of doses or concentrations:
- no
- Remarks:
- Analysis of test item in vehicle for concentration, homogeneity, and stability was not performed, as no feasible analytical method was available.
- Duration of treatment / exposure:
- Days 6 to 20 post-coitum inclusive
- Frequency of treatment:
- daily gavage
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 20 females per dose
- Control animals:
- yes, concurrent vehicle
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: At least once daily 0 to 1 hours post-dose, starting on Day 6 post coitum up to and including the day prior to necropsy.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: On Days 2, 6, 15 and 21 post-coitum
BODY WEIGHT: Yes
- Time schedule for examinations: On Days 2, 6, 9, 12, 15, 18 and 21 post-coitum
FOOD CONSUMPTION : Yes
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
WATER CONSUMPTION :Yes
- Time schedule for examinations: Regular basis throughout the study.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 16 post-coitum
- Organs examined: thyroid gland, kidney, liver, iliac and mandibular lymph node, diaphragm muscle, placenta, skin
- Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: number and distribution of live and dead fetuses - Blood sampling:
- Serum: Yes- Fetal examinations:
- - External examinations: Yes: [all per litter ]
- Soft tissue examinations: Yes: [half per litter]
- Skeletal examinations: Yes: [half per litter ]
- Head examinations: Yes: [half per litter]
- Anogenital distance of all live rodent pups: Yes - Statistics:
- Means, standard deviations (or % coefficient of variation or standard error, when deemed appropriate), percentages, numbers, and/or incidences will be reported as appropriate by dataset.
Parametric
Levene’s test will be used to assess the homogeneity of group variances.
The groups will be compared using an overall one-way ANOVA F-test if Levene’s test is not
significant or the Kruskal-Wallis test if it is significant. If the overall F-test or Kruskal-Wallis
test is found to be significant, then pairwise comparisons will be conducted using Dunnett’s
or Dunn’s test, respectively.
Non-parametric
The groups will be compared using an overall Kruskal-Wallis test. If the overall
Kruskal-Wallis test is found to be significant, then the above pairwise comparisons will be
conducted using Dunn’s test. - Historical control data:
- Charles River Den Bosch has historical data on the background incidence of fetal malformations and developmental variations in this species from the same strain and source
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No test material-related clinical signs were noted during the treatment period.
Any clinical signs noted during the treatment period occurred within the range of background
findings to be expected for rats of this age and strain which are housed and treated under the
conditions in this study and did not show any apparent dose-related trend. At the incidence
observed, these were considered to be unrelated to treatment with the test material. - Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Endocrine findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Serum levels of T3 and T4 were considered to be unaffected by treatment with the test material.
At 100 and 1000 mg/kg/day, TSH levels were higher (1.23x and 1.24x of control, not statistically significant). Considering the small magnitude of the effect and as the mean values were within historical control data1, the increase in TSH was considered to be unrelated to treatment with test material. - Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
Maternal developmental toxicity
- Number of abortions:
- not specified
- Pre- and post-implantation loss:
- no effects observed
- Total litter losses by resorption:
- no effects observed
- Description (incidence and severity):
- The numbers corpora lutea and implantation sites, and pre- and postimplantation loss in the control and test groups were similar and in the range of normal biological variation.
- Early or late resorptions:
- no effects observed
- Description (incidence and severity):
- The numbers corpora lutea and implantation sites, and pre- and postimplantation loss in the control and test groups were similar and in the range of normal biological variation.
- Dead fetuses:
- no effects observed
- Changes in pregnancy duration:
- not specified
- Changes in number of pregnant:
- no effects observed
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: No adverse effects observed
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Reduction in number of live offspring:
- no effects observed
- Changes in sex ratio:
- no effects observed
- Changes in litter size and weights:
- no effects observed
- Anogenital distance of all rodent fetuses:
- no effects observed
- External malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- There were two external malformations observed in this study. Fetus No. 16-L1 in the control group presented with an absent anus and fetus No. 85-R9 at the high dose (1000 mg/kg/day) presented with omphalocele. The single occurrences and/or presence in the control group only ruled out a relationship to the treatment with the test material
- Skeletal malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Skeletal variations were observed in the forelimb, pelvic girdle, (supernumerary) ribs, scapula, skull, sternebra and vertebra and occurred across all groups. However, a relationship to treatment with the test material was ruled out due to infrequent observations, absence of a dose-related incidence trend, and/or only scored in control fetuses.
- Visceral malformations:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Visceral variations were limited to supernumerary liver lobes and convoluted/minimally dilatated ureters. Infrequent occurrences, insignificant differences to the control group and/or occurrence in a control fetus ruled out any relationship to the treatment with the test material
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects observed
Fetal abnormalities
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Developmental effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- No maternal and developmental toxicity was observed for Ta2O5 CERAMIC Grade in a prenatal developmental toxicity study conducted in rats. Following NOAELs for Ta2O5 CERAMIC Grade were established:
Maternal NOAEL: at least 1000 mg/kg/day.
Developmental NOAEL: at least 1000 mg/kg/day. - Executive summary:
In a developmental toxicity study ditantalum pentoxide (99.9 % a.i.) was administered to 22 time-mated female Wistar Han rats by gavage at dose levels of 0, 100, 300, or 1000 mg/kg bw/day from days 6 through 20 of gestation.
There were no treatment-related effects in mortality, clinical signs, body weight, food consumption, or cesarean parameters. The maternal NOAEL is 1000 mg/kg bw/day.
There were no treatment-related effects in developmental parameters. The developmental NOAEL is 1000 mg/kg bw/day.
The developmental toxicity study in the rat is classified acceptable and satisfies the guideline requirement for a developmental toxicity study (OECD 414) in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
